Precision For Medicine, Inc.

In 2019, ProMedDx and GLAS Bio were acquired by Precision for Medicine, part of Precision Medicine Group. This new combination significantly bolstered the selection, scientific prowess and solutions available to customers from a single partner. With over 30 years of industry related experience, we are poised to strategically alter the course, pace, and quality of research. At Precision for Medicine, our global network of patients and clinicians are the foundation to supporting our partners’ critical research. Our direct-to-patient connection ensures our clients’ priorities are served in the most efficient and quality-focused manner.